05:41 AM EDT, 08/07/2024 (MT Newswires) -- Veracyte ( VCYT ) reported Q2 non-GAAP earnings late Tuesday of $0.30 per diluted share, up from $0.12 a year earlier.

Four analysts surveyed by Capital IQ expected a normalized loss of $0.01.

Revenue for the quarter ended June 30 was $114.4 million, up from $90.3 million a year earlier.

Analysts polled by Capital IQ expected $100.2 million.

The company now expects full-year 2024 revenue of $432 million to $438 million, up from its prior guidance of $402 million to $410 million. Analysts surveyed by Capital IQ expect $410.2 million.

Shares of the company rose over 17% in after-hours activity Tuesday.

Price: 25.70, Change: +3.88, Percent Change: +17.78